vs
Side-by-side financial comparison of Strive, Inc. (ASST) and Cardiff Oncology, Inc. (CRDF). Click either name above to swap in a different company.
Strive, Inc. is the larger business by last-quarter revenue ($255.0K vs $243.0K, roughly 1.0× Cardiff Oncology, Inc.). Cardiff Oncology, Inc. runs the higher net margin — -2969.5% vs -75406.7%, a 72437.1% gap on every dollar of revenue. On growth, Cardiff Oncology, Inc. posted the faster year-over-year revenue change (62.0% vs -74.1%). Over the past eight quarters, Strive, Inc.'s revenue compounded faster (77.6% CAGR vs 8.9%).
Strive Asset Management is an American investment management firm founded in 2022. The firm operates mutual funds, exchange-traded products (ETPs), and wealth management services. Headquartered in Columbus, Ohio, it operates as a subsidiary of Strive Enterprises, Inc. and is registered with the U.S. Securities and Exchange Commission (SEC) as an investment adviser.
ASST vs CRDF — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $255.0K | $243.0K |
| Net Profit | $-192.3M | $-7.2M |
| Gross Margin | — | — |
| Operating Margin | -17288.6% | -3221.0% |
| Net Margin | -75406.7% | -2969.5% |
| Revenue YoY | -74.1% | 62.0% |
| Net Profit YoY | -2726.9% | 38.8% |
| EPS (diluted) | $-0.22 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $243.0K | ||
| Q3 25 | $255.0K | $120.0K | ||
| Q2 25 | $173.3K | $121.0K | ||
| Q1 25 | $170.7K | $109.0K | ||
| Q4 24 | $212.8K | $150.0K | ||
| Q3 24 | $984.0K | $165.0K | ||
| Q2 24 | $93.0K | $163.0K | ||
| Q1 24 | $124.8K | $205.0K |
| Q4 25 | — | $-7.2M | ||
| Q3 25 | $-192.3M | $-11.3M | ||
| Q2 25 | $-8.9M | $-13.9M | ||
| Q1 25 | $-3.7M | $-13.4M | ||
| Q4 24 | $-4.1M | $-11.8M | ||
| Q3 24 | $-6.8M | $-11.9M | ||
| Q2 24 | $-5.9M | $-11.8M | ||
| Q1 24 | $-4.8M | $-10.0M |
| Q4 25 | — | -3221.0% | ||
| Q3 25 | -17288.6% | -9978.3% | ||
| Q2 25 | -1553.9% | -12212.4% | ||
| Q1 25 | -970.5% | -13194.5% | ||
| Q4 24 | -5889.5% | -8381.3% | ||
| Q3 24 | -712.4% | -7637.0% | ||
| Q2 24 | -1857.2% | -7696.3% | ||
| Q1 24 | -1110.9% | -5333.2% |
| Q4 25 | — | -2969.5% | ||
| Q3 25 | -75406.7% | -9381.7% | ||
| Q2 25 | -5122.4% | -11523.1% | ||
| Q1 25 | -2195.6% | -12324.8% | ||
| Q4 24 | -1935.5% | -7858.0% | ||
| Q3 24 | -691.3% | -7184.8% | ||
| Q2 24 | -6313.1% | -7225.8% | ||
| Q1 24 | -3837.7% | -4883.4% |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $-0.22 | $-0.17 | ||
| Q2 25 | $-0.17 | $-0.21 | ||
| Q1 25 | $-0.13 | $-0.20 | ||
| Q4 24 | $-5.62 | $-0.22 | ||
| Q3 24 | $-3.06 | $-0.25 | ||
| Q2 24 | $-0.58 | $-0.26 | ||
| Q1 24 | $-0.49 | $-0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $109.1M | $58.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.4M | $45.4M |
| Total Assets | $792.6M | $61.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $58.3M | ||
| Q3 25 | $109.1M | $60.6M | ||
| Q2 25 | $2.5M | $71.0M | ||
| Q1 25 | $4.2M | $79.9M | ||
| Q4 24 | $6.2M | $91.7M | ||
| Q3 24 | $2.1M | $57.7M | ||
| Q2 24 | $1.9M | $60.3M | ||
| Q1 24 | $1.9M | $67.2M |
| Q4 25 | — | $45.4M | ||
| Q3 25 | $779.4M | $48.8M | ||
| Q2 25 | $10.7M | $58.6M | ||
| Q1 25 | $19.6M | $70.9M | ||
| Q4 24 | $23.3M | $82.9M | ||
| Q3 24 | $27.5M | $49.4M | ||
| Q2 24 | $5.4M | $52.4M | ||
| Q1 24 | $11.3M | $60.9M |
| Q4 25 | — | $61.9M | ||
| Q3 25 | $792.6M | $63.8M | ||
| Q2 25 | $3.3M | $75.7M | ||
| Q1 25 | $5.0M | $84.8M | ||
| Q4 24 | $28.2M | $97.2M | ||
| Q3 24 | $2.6M | $62.9M | ||
| Q2 24 | $2.4M | $66.1M | ||
| Q1 24 | $2.1M | $74.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.0M | $-6.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-6.0M | ||
| Q3 25 | $-14.0M | $-10.8M | ||
| Q2 25 | $-1.7M | $-8.3M | ||
| Q1 25 | $-1.6M | $-12.8M | ||
| Q4 24 | $-21.6M | $-10.3M | ||
| Q3 24 | $-13.2M | $-10.5M | ||
| Q2 24 | $-1.3M | $-9.2M | ||
| Q1 24 | $-1.0M | $-7.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-10.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-21.6M | — | ||
| Q3 24 | $-13.4M | — | ||
| Q2 24 | $-1.3M | — | ||
| Q1 24 | $-1.1M | $-7.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | -9043.3% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -10161.2% | — | ||
| Q3 24 | -1360.3% | — | ||
| Q2 24 | -1379.4% | — | ||
| Q1 24 | -844.7% | -3814.6% |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | 15.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 11.3% | 0.0% | ||
| Q3 24 | 18.8% | 0.0% | ||
| Q2 24 | 3.1% | 0.0% | ||
| Q1 24 | 9.5% | 39.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
